|Conditional recommendation based on low-quality evidence; may consider an IL-12/23i if the patient has IBD or if the patient prefers less frequent drug administration.| |
|7. Switch to an IL-17i biologic over abatacept (PICO 72)|Low (90â€“93, 95, 103, 104, 112)|
|Conditional recommendation based on low-quality evidence; may consider abatacept if the patient prefers IV dosing or in patients with recurrent or serious infections.| |